A5102729575- Intraperitoneal and Appendiceal Malignancies
- Appendicitis Diagnosis and Management
- Ovarian cancer diagnosis and treatment
- Occupational and environmental lung diseases
- Colorectal Cancer Surgical Treatments
- Neuroendocrine Tumor Research Advances
- Hernia repair and management
- Nanoparticle-Based Drug Delivery
- Cancer Treatment and Pharmacology
- Colorectal and Anal Carcinomas
- Advances in Oncology and Radiotherapy
- Colorectal Cancer Treatments and Studies
- Intestinal and Peritoneal Adhesions
- Vascular Malformations and Hemangiomas
- Gastrointestinal Tumor Research and Treatment
- Genetic factors in colorectal cancer
- Uterine Myomas and Treatments
- Colorectal Cancer Screening and Detection
- Cardiac, Anesthesia and Surgical Outcomes
- Clinical practice guidelines implementation
- Ultrasound and Hyperthermia Applications
- Pancreatic and Hepatic Oncology Research
- Hepatocellular Carcinoma Treatment and Prognosis
- Neuroblastoma Research and Treatments
- Delphi Technique in Research
Basingstoke and North Hampshire Hospital
2011-2025
Hampshire Hospitals NHS Foundation Trust
2014-2023
London Clinic
2023
Addenbrooke's Hospital
2019
Hôpital Lyon Sud
2009
Institut Gustave Roussy
2003-2009
Royal Prince Alfred Hospital
2009
Hospices Civils de Lyon
2009
James Cook University Hospital
2008-2009
Newcastle University
2007
Purpose This multi-institutional registry study evaluated cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for diffuse malignant peritoneal mesothelioma (DMPM). Patients and Methods A data that included 405 patients DMPM treated by a uniform approach used CRS HIPEC was established. The primary end point overall survival. secondary evaluation of prognostic variables Results Follow-up complete in 401 (99%). median follow-up period the who were alive...
In Brief Objective: The aim of this study was to analyze the survival patients with peritoneal dissemination appendiceal malignancy having incomplete cytoreductive surgery. Summary Background Data: Cytoreductive surgery plus perioperative intraperitoneal chemotherapy has emerged as a new and potentially curative treatment option for mucinous tumors. goal is remove all visible disease. Nevertheless, in some patients, complete cytoreduction not possible. Methods: Over 30-year period, 645...
The objective of this retrospective study was to evaluate the influence neoadjuvant systemic chemotherapy on patients with colorectal carcinomatosis before a curative procedure.Peritoneal (PC) from cancer may be treated intent by cytoreductive surgery (CRS) and hyperthermic intraperitoneal (HIPEC). role perioperative for particular metastatic disease remains unclear.One hundred twenty PC were consecutively 131 procedures combining CRS HIPEC. response assessed data previous explorative and/or...
Abstract Objective Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is the best treatment of several peritoneal surface malignancies. Isolated recurrence may be treated by iterative procedures. The aim this study was to evaluate immediate postoperative and long‐term results after CRS‐HIPEC. Methods From 1990 2010, 30 patients isolated underwent procedures combining Results Origins carcinomatosis were ovarian, colorectal, pseudomyxoma peritonei,...
Introduction Multidisciplinary team (MDT) meetings are now considered part of the standard care for decision-making and management patients with cancer. However, most MDTs face capacity issues supplementary approaches should be considered. We report our experience a novel clinical radiological assessment meeting (CRAM) as 'mini-MDT' to expedite enhance function parallel specialist MDT. Methods A retrospective analysis new referrals high-volume peritoneal malignancy unit between September...
Three distinct morphologic types of pseudomyxoma peritonei syndrome have been defined: disseminated peritoneal adenomucinosis (DPAM), mucinous carcinoma (PMCA), and a hybrid type. Prognosis is best in patients with DPAM; unfortunately, some DPAM succumb to rapidly progressive disease process.We identified subset 11 histopathology but clinical course showing an invasive process. As comparison group, from database 501 peritonei, we selected 22 age- sex-matched controls histology who are alive...